Benign Masseteric Hypertrophy Clinical Trial
Official title:
A Double-blind, Randomized, Placebo-controlled, Multi-center, Phase Ⅲ Study to Evaluate the Efficacy and Safety of NABOTA® in Subjects With Benign Masseteric Hypertrophy
This Study is A Double-blind, Randomized, Placebo-controlled, Multi-center, Phase III Study to Evaluate the Efficacy and Safety of DWP450 in Subjects With Benign Masseteric Hypertrophy
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04443244 -
Evaluate the Safety and Efficacy of Botulax® in Subjects With Benign Masseteric Hypertrophy
|
Phase 2 | |
Recruiting |
NCT05964257 -
To Evaluate the Efficacy and Safety of LIZTOX in Subjects With Benign Masseteric Hypertrophy
|
Phase 3 | |
Not yet recruiting |
NCT03369990 -
DWP450 Treatment in Subjects With Benign Masseteric Hypertrophy
|
Phase 2 |